ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential
- Status
- RECRUITING
- Phase
- N/A
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SLV-154 Treatment of Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs
- Status
- NOT_YET_RECRUITING
- Phase
- NA
QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.
- Status
- RECRUITING
- Phase
- N/A
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1